跳至主要内容
临床试验/NCT03389152
NCT03389152已完成不适用

Evaluation of SWE as a Predictive Tool for Progression of Chronic Liver Diseases

SuperSonic Imagine0 个研究点目标入组 2,148 人开始时间: 2007年7月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,148
主要终点
Liver disease progression rate

研究概览

简要总结

This study is a multicenter individual patient-based meta-analysis that will assess the performances of liver stiffness measurements performed with supersonic shear imaging shearwave elastography (SSI-SWE) in patients with liver fibrosis to predict progression of chronic liver disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who had received a liver ultrasound exam at baseline for a suspected chronic fibrotic liver disease of viral and/or steatotic origin,
  • Patients who had reached the age of majority in their countries, at baseline,
  • Patients with a baseline liver biopsy for histological evaluation of liver fibrosis with a length ≥ 15 mm paraffin sections (except if cirrhosis),
  • Patients for whom a minimum length of clinical follow-up from baseline of 1 year had been recorded

排除标准

  • Cause of chronic liver disease other than viral, ALD or NAFLD ( hemochromatosis, autoimmune hepatitis, biliary tract disease intrahepatic...)
  • Any systemic, viral hepatitis and HIV co-infection

结局指标

主要结局

Liver disease progression rate

时间窗: Minimum of 28 days follow-up

Clinical signs of liver decompensation

Mortality rate

时间窗: Minimum of 28 days follow-up

Patient's death

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验